Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$5.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| May 4 | TVTX | Travere Therapeutics, Inc. | AGRANT◷◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 22,500 | — | — | +5.2% | Open the original filing on SEC.gov |
| Apr 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 20 | $42.66 | $853 | 0.0% | Open the original filing on SEC.gov |
| Apr 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 7,165 | $41.75 | $299.1K | -1.6% | Open the original filing on SEC.gov |
| Apr 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 56,815 | $41.01 | $2.3M | -11.4% | Open the original filing on SEC.gov |
| Apr 13 | TVTX | Travere Therapeutics, Inc. | AGRANT◷ | 64,000 | — | — | +14.8% | Open the original filing on SEC.gov |
| Apr 1 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 60,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 25,098 | $31.46 | $789.6K | -5.5% | Open the original filing on SEC.gov |
| Apr 1 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 34,902 | $30.55 | $1.1M | -7.1% | Open the original filing on SEC.gov |
| Apr 1 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 60,000 | $15.46 | $927.6K | +13.9% | Open the original filing on SEC.gov |